|
| |
NEUMED NERVE PACE
$2995.00
NEW IN BOX
SEALED IN PLASTIC
COMPLETE WITH MANUALS AND SOFTWARE
 The DTX-200
DexaCareŽ $7500.00
|
The DTX-200 DexaCareŽ is a unique x-ray
densitometer for the assessment of bone
density in the distal part of the
forearm. The forearm is an excellent
site because the forearm is
representative of the total body bone
mass. The DTX-200 DexaCareŽ has won
world-wide recognition for enabling
fast, easy, reliable, inexpensive and
cost-effective assessment as well as
follow-up of bone density. This has led
to several thousand units being
installed throughout the world. |
|
|
|
|
|
The DTX-200 DexaCareŽ is a unique dual energy
X-ray bone densitometer that gives you the
opportunity to assess and follow up on the
patients' bone density. With the DTX-200
DexaCareŽ the physician has an easy and
cost-effective method with a throughput of up to
50 examinations per working day.
The DTX-200 DexaCareŽ assesses forearm bone
density with optimised precision and accuracy.
One of the unique features of the DTX-200
DexaCareŽ is the automatic identification of the
8 mm distance between ulna and radius. This
ensures that the same area is assessed every
time. The excellent in vivo accuracy (>97%) and
in vivo precision (>99%) makes DTX-200 DexaCareŽ
highly suitable for assessment of bone density
and follow-up.
The DTX-200 DexaCareŽ is a truly automated
system. Every calibration, positioning,
assessment and calculation is performed
automatically, minimising operator errors. The
straight forward procedures together with
minimal operator intervention make the DTX-200
DexaCareŽ instantly operational. The extensive
database allows comparison with age-matched
peers (Z-score) and premenopausal peers
(T-score).
The DTX-200 DexaCareŽ can be placed in the
examination room without special installation
and shielding requirements. The outstanding
calibration system makes it possible to finish
an examination within 4.5 minutes. Due to its
integrated, dynamic approach, the DTX-200
DexaCareŽ provides the facility to give the
answer to the patient today.
It is well established that the effect of a
treatment is best seen in trabecular bone. The
new Region of Interest (nROI) developed
specifically for the DTX-200 DexaCareŽ assesses
the bone density in the ultra-distal part of the
forearm where the bone composition is 65%
trabecular bone and 35% cortical bone.
|
|
|
|
|
